Peripheral Artery Disease (PAD)

This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia.

News

One-Year Results of the DISAPEAR Registry Positive for Absorb Stent

November 8, 2019 — The Absorb bioresorbable stent (BVS) demonstrated good patency and clinical outcomes in patients with ...

November 08, 2019

News | Stents Bioresorbable

Bioresorbable Stent Shows Good 5-Year Outcomes in ABSORB BTK Trial

November 7, 2019 — Although the Abbott Absorb fully bioresorbable drug-eluting stent (DES) was taken off the market due ...

November 07, 2019

In.Pact Admiral drug-coated balloon (DCB). #VIVA #VIVA19 #VIVA2019

News | Drug-Eluting Balloons

Drug-coated Balloon Maintains Good Outcomes in 4-Year IN.PACT Global Study Data

November 7, 2019 — Real-world, four-year study results of the In.Pact Admiral drug-coated balloon (DCB) demonstrate long ...

November 07, 2019

The AngioDynamics/Eximo Medical B-Laser represents a new atherectomy device. #VIVA2019 #VIVA #VIVA19

News | Atherectomy Devices

No Difference Between Drug-coated Balloons and Plain Balloons After Laser Atherectomy

November 7, 2019 — There was no difference between drug-coated balloons (DCB) vs. plain old balloon angioplasty (POBA) ...

November 07, 2019

The final, long-term, patient-level data for the Cook Medical Zilver PTX drug-eluting stent (DES) were evaluated to determine if there is an increased mortality risk due to paclitaxel, but was no difference was seen in the five-year mortality rates compared to control patients. #VIVA19 #VIVA #VIVA2019

Feature | Stents Peripheral | Dave Fornell, Editor

No Increased Long-Term Mortality for the Paclitaxel-Coated Zilver PTX Stent

November 6, 2019 – The final, long-term, patient-level data for the Cook Medical Zilver PTX drug-eluting stent (DES) ...

November 06, 2019

The Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, #VIVA2019 #VIVA #VIVA19

News | Drug-Eluting Balloons

Safety and Efficacy Sustained Over Two Years in Selution Drug-eluting Balloon First-in-Human Trial

November 6, 2019 – Positive, two-year data from the first-in-human study of Selution SLR, MedAlliance’s novel sirolimus ...

November 06, 2019

Eluvia and Ranger PAD devices from Boston Scientific. #VIVA19 #VIVA2019 #VIVA

News | Peripheral Artery Disease (PAD)

Positive Data for the Ranger Drug-coated Balloon and Eluvia Vascular Stent

November 6, 2019 – Boston Scientific announced positive data for two of its devices within the peripheral drug-eluting ...

November 06, 2019

Viva conference late breaking clinical trials, #VIVA19 #VIVA #VIVA2019

Feature | VIVA

VIVA 2019 Late-breaking Clinical Trials

November 14, 2019 — The results of the 21 late-breaking clinical trials presented for the first time at V ascular ...

November 14, 2019

News | Drug-Eluting Balloons

Philips Introduces New 200mm and 150mm Stellarex 0.035-inch Low-dose Drug-coated Balloons

October 15, 2019 — Royal Philips introduced two new balloons to its Stellarex 0.035-inch low-dose drug-coated balloon ...

October 15, 2019

An independent analysis of Lutonix 035 drug-coated balloon (DCB) patient-level data showed no statistically significant mortality increase. This was one of the first major reviews of trial data for patients who were treated with a paclitaxel coated device used in peripheral vessels following a meta analysis study of paclitaxel device trials published in December 2018 that showed a mortality safety signal. This was a major discussion during the FDA townhall meeting at the #TCT2019.

News | Drug-Eluting Balloons

LEVANT Trial Data Shows Safety of Drug-Coated Balloon Shown

October 10, 2019 — An independent analysis of Lutonix 035 drug-coated balloon (DCB) patient-level data showed no ...

October 10, 2019

News | Stent Grafts

PQ Bypass Granted IDE Approval to Start TORUS SFA Stent Graft Pivotal Study

October 8, 2019 — PQ Bypass Inc. announced it has received full approval of its investigational device exemption (IDE) ...

October 08, 2019

News | Drug-Eluting Balloons

Virtue Sirolimus-Eluting Balloon Earns FDA Breakthrough Device Designation

September 20, 2019 — Orchestra BioMed Inc., in partnership with Terumo Corp. announced the company has secured ...

September 20, 2019

Technology | Atherectomy Devices

Rex Medical Receives 510(k) Clearance for Revolution Peripheral Atherectomy System

September 13, 2019 — Rex Medical L.P. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

September 13, 2019

Feature | Peripheral Artery Disease (PAD) | Jeff Zagoudis, Associate Editor

FDA Panel Recommends Continued Use of Paclitaxel-coated Peripheral Devices

August 28, 2019 — The U.S. Food and Drug Administration (FDA) released an updated MedWatch Alert this month on the ...

August 28, 2019

News | Peripheral Artery Disease (PAD)

New Report Says Concept Medical Positioned to Disrupt Peripheral Market

August 27, 2019 — Concept Medical was recently granted Breakthrough Therapy designation by the U.S. Food and Drug ...

August 27, 2019